Immune resilience in response to cancer therapy Joanina K. GicobiWhitney BarhamHaidong Dong Editorial 04 October 2020 Pages: 2165 - 2167
Augmenting engineered T-cell strategies in solid cancers through epigenetic priming Aaraby Y. NielsenMaria OrmhøjMorten F. Gjerstorff Review 10 July 2020 Pages: 2169 - 2178
In vitro 4-1BB stimulation promotes expansion of CD8+ tumor-infiltrating lymphocytes from various sarcoma subtypes Morten NielsenAnders Krarup-HansenNiels Junker Original Article 29 May 2020 Pages: 2179 - 2191
Differences in the sensitivity of classically and alternatively activated macrophages to TAK1 inhibitor-induced necroptosis Zsófia VargaTamás MolnárGábor Koncz Original Article Open access 29 May 2020 Pages: 2193 - 2207
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50% Alessio CortelliniMarcello TiseoGiampiero Porzio Original Article 30 May 2020 Pages: 2209 - 2221
Differences in PD-1 expression on CD8+ T-cells in chronic myeloid leukemia patients according to disease phase and TKI medication Min Young LeeChan-Jeoung ParkJe-Hwan Lee Original Article 30 May 2020 Pages: 2223 - 2232
Expression profiles and function of IL6 in polymorphonuclear myeloid-derived suppressor cells Mohammed L. IbrahimChunwan LuKebin Liu Original Article 01 June 2020 Pages: 2233 - 2245
Exploratory open-label clinical study to determine the S-588410 cancer peptide vaccine-induced tumor-infiltrating lymphocytes and changes in the tumor microenvironment in esophageal cancer patients H. DaikoT. MarafiotiT. Kojima Original Article Open access 04 June 2020 Pages: 2247 - 2257
Cell composition and expansion strategy can reduce the beneficial effect of AKT-inhibition on functionality of CD8+ T cells Charlotte M. MoussetWillemijn HoboHarry Dolstra Original Article Open access 05 June 2020 Pages: 2259 - 2273
Infiltration of T cells promotes the metastasis of ovarian cancer cells via the modulation of metastasis-related genes and PD-L1 expression Jing-Jing WangMichelle Kwan-Yee SiuKaren Kar-Loen Chan Original Article 05 June 2020 Pages: 2275 - 2289
Influence of antigen density and immunosuppressive factors on tumor-targeted costimulation with antibody-fusion proteins and bispecific antibody-mediated T cell response Sabrina SapskiNadine BehaDafne Müller Original Article Open access 05 June 2020 Pages: 2291 - 2303
Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer Qilai LongAi-Hong MaChong-Xian Pan Original Article 06 June 2020 Pages: 2305 - 2317
Micro-environmental cross-talk in an organotypic human melanoma-in-skin model directs M2-like monocyte differentiation via IL-10 Elisabetta MichielonMarta López GonzálezSusan Gibbs Original Article Open access 07 June 2020 Pages: 2319 - 2331
CD200 is overexpressed in neuroblastoma and regulates tumor immune microenvironment Chao XinJianmin ZhuHua Zhu Original Article 08 June 2020 Pages: 2333 - 2343
ADRB3 expression in tumor cells is a poor prognostic factor and promotes proliferation in non-small cell lung carcinoma Meng ZhengZhiling ZhouShuguang Lin Original Article Open access 08 June 2020 Pages: 2345 - 2355
Metabolomic profiling of tumor-infiltrating macrophages during tumor growth Naoki UmemuraMasahiro SugimotoHiroshi Sakagami Original Article Open access 09 June 2020 Pages: 2357 - 2369
IL-6-induced CD39 expression on tumor-infiltrating NK cells predicts poor prognosis in esophageal squamous cell carcinoma Yujia ZhengYu LiLan Huang Original Article 10 June 2020 Pages: 2371 - 2380
Clinicopathological factors associated with tumor-infiltrating lymphocyte reactivity in breast cancer Heejae LeeYoung-Ae KimHee Jin Lee Original Article 11 June 2020 Pages: 2381 - 2391
Phase I trial evaluating safety and efficacy of intratumorally administered inflammatory allogeneic dendritic cells (ilixadencel) in advanced gastrointestinal stromal tumors Robin FröbomErik BerglundRobert Bränström Original Article Open access 13 June 2020 Pages: 2393 - 2401
Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer Mingjia LiDaniel SpakowiczDwight H. Owen Research Report 29 July 2020 Pages: 2403 - 2408
Silent acute appendicitis revealed by PET-CT during treatment with ipilimumab and nivolumab: a new immune-related adverse event C. MangasS. Leoni-ParvexV. Spataro Letter to the Editors 22 September 2020 Pages: 2409 - 2410